Pharmafile Logo
Pharmafocus logo
Advanced Search

Lonza lined up as backup manufacturer for Agennix’s talactoferrin

April 16, 2012
Manufacturing and Production Agennix, DSM Pharmaceutical, Lona

Agennix has taken a ‘belt-and-braces’ approach to manufacturing its lead pipeline product, signing a new deal with Lonza a month …

News
Risperdal image

J&J fined after ‘lying to patients for profit’

April 16, 2012
Medical Communications, Sales and Marketing J&J, JJ, Janssen, Risperdal, US

A US judge has slapped a $1.19 billion fine on Johnson & Johnson after it was found to be downplaying …

News

South Africa makes pharma a ‘designated’ industry

April 16, 2012
Manufacturing and Production DTI, Rob Davies, South Africa

The government of South Africa has said it will only buy certain pharmaceutical products that are manufactured in domestic facilities, …

News

New health boards met with cautious optimism

April 16, 2012
Sales and Marketing NHS, king's fund

The new joined-up health and wellbeing boards have been well received by The King’s Fund, but the think tank warns …

News
Merck image

Merck signs deal with venture capitalists

April 16, 2012
Research and Development, Sales and Marketing Flagship Ventures, Merck

Merck has entered a deal with a US venture capital firm specialising in life sciences to help build the manufacturer’s …

News
Aesica image

Aesica approval sets up further US expansion

April 16, 2012
Manufacturing and Production Aesica, FDA

UK contract manufacturer and ingredient supplier Aesica says its manufacturing facility at Queenborough has successfully passed its first FDA inspection …

News

Diabetes UK launches new peer support service

April 16, 2012
Diabetes UK, diabetes, peer support

Diabetes UK has launched a new support service that puts people with diabetes in touch with others who have the …

News

Senior team moves at ROCK medical communications

April 16, 2012
Business Services, Medical Communications, Sales and Marketing Rock Medical Communications

ROCK medical communications has appointed Eric Hansen as director and promoted Clare Pressney to associate director.  Most recently Hansen spent …

Appointment

MSI appoints new partner

April 16, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI Consultancy, Sanofi, appointment

Pharma consultancy firm MSI has announced the appointment of a new partner.  Steve Mather takes up this senior position with …

Appointment

UK government invests in new radiotherapy treatment

April 16, 2012
Sales and Marketing Cancer, Photon beam therapy, Proton beam therapy, prostate cancer, radiotherapy

The government is to invest £250 million in a cutting-edge radiotherapy treatment that should benefit 1,500 cancer patients in the …

News

Cloud computing ‘eagerly anticipated’ by healthcare

April 16, 2012
Medical Communications, Sales and Marketing Cloud Computing, digital, healthcare

The use of cloud computing in healthcare is expected to grow significantly in the coming years, but developed countries may …

News
takeda_tokyo_hq

Takeda to buy gout specialist URL Pharma for $800m

April 16, 2012
Research and Development, Sales and Marketing R&D, Takeda, acquisition, gout

Takeda is set to purchase URL Pharmaceuticals for $800 million, helping offset the loss of its blockbuster ulcer drug Prevacid.  …

News

Access to new cancer drugs limited in Brazil and Mexico

April 13, 2012
Sales and Marketing Brazil, Cancer, Mexico, avastin, emerging markets

Between one-quarter and one-third of patients in Brazil and Mexico who are eligible for treatment with new cancer drugs do …

News

Januvia gains renal impairment licence in UK

April 13, 2012
Sales and Marketing Januvia, MSD, Merck, diabetes, renal impairment

Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …

News

UCB launches ‘Parkinson’s Well-Being Map’

April 13, 2012
Medical Communications Parkinson's disease, UCB

UCB has launched a new visual tool to help people with Parkinson’s Disease to discuss their health and symptoms with …

News
Steve Yang

Innovating in China’s pharma market

April 12, 2012
Research and Development AstraZeneca, China, R&D, Steve Yang, emerging markets

The challenges that China and the wider Asia region face in healthcare represent big opportunities for multinational pharma companies. Cases of …

Feature

ViiV Healthcare appoints Just:: Health PR

April 12, 2012
Medical Communications, Sales and Marketing HIV/AIDS, Just::, PR, ViiV

ViiV Healthcare has appointed Just:: Health PR to work on an integrated political and public relations initiative that will engage …

News
Roche

Roche on target despite European shrinkage

April 12, 2012
Sales and Marketing Illumina, Q1 2012, Roche

Roche saw its business grow in the first three months of the year, thanks to strong showings from hepatitis C …

News

EMA backs full access to trial data

April 12, 2012
Business Services, Research and Development, Sales and Marketing EMA, clinical trial data, data disclosure, regulatory affairs, transparency

The European Medicines Agency says it wants to open up access to full clinical trial data, but warns that some …

News

immatics appoints Dr Rainer Kramer as its new
 chief business officer

April 12, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

immatics biotechnologies, a biopharma company developing therapeutic cancer vaccines, has appointment Dr Rainer Kramer as its new chief business officer. …

Appointment
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026